Broomfield, CO, October 22, 2015 --(PR.com
)-- MedAware Systems, Inc. announced today that Dr. Aaron L Friedman is joining the Company’s Scientific Advisory Board.
Dr. Aaron Friedman served as the Vice President for Health Sciences and Dean of the Medical School at the University of Minnesota. Prior to his appointment as vice president and dean, Dr. Friedman was head of the Department of Pediatrics and pediatrician-in-chief at University of Minnesota Masonic Children’s Hospital. He also served as Chair of Pediatrics at the University of Wisconsin and Brown University.
Dr. Friedman served on the Board of Directors of the American Board of Pediatrics and served as its Secretary/Treasurer and Chair of the Board. He chaired the American Academy of Pediatrics Committee on Professional Education. He also served as the chair of the steering committee for an NIH sponsored clinical trial while at Brown University. His research centered on amino acid transport and factors influencing growth in chronic renal failure.
He is a pediatric nephrologist and has been awarded the Henry L. Barnett Award from the American Academy of Pediatrics for his contributions to children with kidney disease and to the pediatric nephrology community.
“Dr. Friedman’s long history of leadership in healthcare, coupled with his extensive clinical experience will provide invaluable guidance for us as we further develop our database of medical research information,” said Dr. Zung Vu Tran, Founder and Chief Science Officer for MedAware Systems. He adds, “With his extensive experience at the University of Minnesota, University of Wisconsin, and Brown University, Dr. Friedman will be instrumental in helping us clearly define and articulate the unique value we provide to academic medical institutions.”
About MedAware Systems, Inc.
MedAware Systems is a Beta stage company providing healthcare professionals and their patients immediate and actionable information on evidence-based medical treatments. This new Scientific-Data-as-a-Service (SDAAS)™ solves the problem of making the vast and chaotic body of human clinical trials research instantly available, comprehensible, and indispensable in determining the patient plan of care.